References
- Swerdlow S, Campo E, Harris N, et al. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. Lyon: IARC; 2017. p. 330–334.
- Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–3734.
- Hochberg J, El-Mallawany NK, Abla O. Adolescent and young adult non-Hodgkin lymphoma. Br J Haematol. 2016;173(4):637–650.
- Wästerlid T, Brown PN, Hagberg O, et al. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Ann Oncol. 2013;24(7):1879–1886. Available from: http://dx.doi.org/10.1093/annonc/mdt058.
- Dunleavy K. Approach to the diagnosis and treatment of adult Burkitt’s lymphoma. JOP. 2018;14(11):665–671.
- Costa LJ, Xavier AC, Wahlquist AE, et al. Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood. 2013;121(24):4861–4867.
- Castillo JJ, Winer ES, Olszewski AJ. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the surveillance, epidemiology, and end results database. Cancer. 2013;119(20):3672–3679.
- Xuereb G, Borg J, Apap K, et al. The snoring 2-year-old boy: a case of primary nasopharyngeal Burkitt’s lymphoma. BMJ Case Rep. 2020;13(1):e233536.
- Quimby AE, Caulley L, Rodin D, et al. Primary Burkitt lymphoma of the supraglottic larynx: a case report and review of the literature. J Med Case Rep. 2017;11:1–6.
- Storck K, Brandstetter M, Keller U, et al. Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med. 2019;15(1):4–11.
- Arboleda LPA, Hoffmann IL, Cardinalli IA, et al. Demographic and clinicopathologic distribution of head and neck malignant tumors in pediatric patients from a Brazilian population: a retrospective study. J Oral Pathol Med. 2018;47(7):696–705.
- Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39(7_suppl):72–74.
- Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3067.
- Rosolen A, Perkins SL, Pinkerton CR, et al. Revised international pediatric non-Hodgkin lymphoma staging system. J Clin Oncol. 2015;33(18):2112–2118.
- Arboe B, El-Galaly TC, Clausen MR, et al. The Danish national lymphoma registry: coverage and data quality. PLoS One. 2016;11(6):e0157999–12.
- Schrøder H, Johnsen SP, Larsson H, et al. The Danish registry of childhood cancer. Ugeskr Laeger. 2012;174:2542.
- Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health. 2011;39(7_suppl):26–29.
- Roy SF, Ghazawi FM, Le M, et al. Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemic. Curr Oncol. 2020;27(2):83–89.
- Hong X, Khalife S, Bouhabel S, et al. Rhinologic manifestations of Burkitt Lymphoma in a pediatric population: case series and systematic review. Int J Pediatr Otorhinolaryngol. 2019;121:127–136.